Literature DB >> 8463369

Mental development in late infancy after prenatal exposure to benzodiazepines--a prospective study.

G Viggedal1, B S Hagberg, L Laegreid, M Aronsson.   

Abstract

Seventeen infants born to mothers who used benzodiazepines (BZD) throughout pregnancy were followed prospectively and compared with 29 infants born to mothers who had not used psychoactive substances. On the Griffiths' Developmental Scale, the BZD-exposed infants demonstrated consistently lower mean GQs and DQs for all subscales at 5, 10 and 18 months of age. The differences in GQ reached statistical significance at 10 and 18 months. The DQs differed significantly for all subscales at 10 months and for the personal-social behaviour and hearing and speech subscales at 18 months of age. We suggest that prenatal exposure to BZD may cause a general delay in mental development up to 18 months of age.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8463369     DOI: 10.1111/j.1469-7610.1993.tb00993.x

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  14 in total

Review 1.  Consequences of prenatal toxin exposure for mental health in children and adolescents: a systematic review.

Authors:  Justin H G Williams; Louise Ross
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-01-02       Impact factor: 4.785

Review 2.  Treating mood disorders during pregnancy: safety considerations.

Authors:  Malin Eberhard-Gran; Anne Eskild; Stein Opjordsmoen
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 3.  Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review.

Authors:  Hanan El Marroun; Tonya White; Frank C Verhulst; Henning Tiemeier
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-05-27       Impact factor: 4.785

Review 4.  Antiepileptic drugs and neurodevelopment.

Authors:  Gholam K Motamedi; Kimford J Meador
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

Review 5.  Treatment of anxiety during pregnancy: effects of psychotropic drug treatment on the developing fetus.

Authors:  C McGrath; A Buist; T R Norman
Journal:  Drug Saf       Date:  1999-02       Impact factor: 5.606

Review 6.  Neurodevelopmental effects of antiepileptic drugs.

Authors:  Kimford J Meador
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

7.  Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age.

Authors:  Ingvild Odsbu; Svetlana Skurtveit; Randi Selmer; Christine Roth; Sonia Hernandez-Diaz; Marte Handal
Journal:  Eur J Clin Pharmacol       Date:  2014-12-30       Impact factor: 2.953

Review 8.  Cognitive outcomes of prenatal antiepileptic drug exposure.

Authors:  Katherine Inoyama; Kimford J Meador
Journal:  Epilepsy Res       Date:  2015-05-02       Impact factor: 3.045

9.  Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies.

Authors:  L R Dolovich; A Addis; J M Vaillancourt; J D Power; G Koren; T R Einarson
Journal:  BMJ       Date:  1998-09-26

10.  Association Between Prenatal Valproate Exposure and Performance on Standardized Language and Mathematics Tests in School-aged Children.

Authors:  Lars Skou Elkjær; Bodil Hammer Bech; Yuelian Sun; Thomas Munk Laursen; Jakob Christensen
Journal:  JAMA Neurol       Date:  2018-06-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.